Literature DB >> 26106175

Successful living donor liver transplantation of fulminant liver failure due to isoniazid prophylaxis.

Tuğrul Çakır1, Cengiz Ara2, Hacı Vural Soyer2, Suleyman Koc2.   

Abstract

Progressive liver failure is rarely seen in tuberculosis chemoprophylaxis with isoniazid. We present a case of a 32-year-old woman admitted to our clinic reporting abdominal pain, nausea and vomiting for 2 days. The initial diagnosis was fulminant toxic hepatitis due to isoniazid chemoprophylaxis, which was treated successfully with living donor transplantation. Tuberculosis continues to be a significant public health problem. Isoniazid-related hepatotoxicity is extremely rare in adults. The only treatment in cases of fulminant liver failure is orthotopic liver transplantation from a deceased or living donor. If a deceased donor is not available or the patient refuses this treatment, living donor transplantation is the only choice. Although rare, isoniazid used as protective therapy for pulmonary tuberculosis can lead to fulminant liver failure. When cadaveric liver transplantation is not available, living donor liver transplantation is vital. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26106175      PMCID: PMC4480103          DOI: 10.1136/bcr-2015-209448

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Toxic hepatitis with isoniazid and rifampin. A meta-analysis.

Authors:  M A Steele; R F Burk; R M DesPrez
Journal:  Chest       Date:  1991-02       Impact factor: 9.410

2.  Isoniazid-related fulminant hepatic failure in a child: assessment of the native liver's early regeneration after auxiliary partial orthotopic liver transplantation.

Authors:  Umberto Cillo; Marco Bassanello; Alessandro Vitale; Lorenzo D'Antiga; Giacomo Zanus; Alberto Brolese; Patrizia Burra; Francesco Antonio Ciarleglio; Graziella Guariso; Lucia Zancan; Maria Guido; Davide Francesco D'Amico
Journal:  Transpl Int       Date:  2004-11-25       Impact factor: 3.782

3.  Acute hepatic failure in seven patients after prophylaxis and therapy with antituberculous agents. Successful treatment with orthotopic liver transplantation.

Authors:  B R Meyers; M Halpern; P Sheiner; M H Mendelson; C Miller; M Schwartz; E Mor
Journal:  Transplantation       Date:  1994-08-15       Impact factor: 4.939

Review 4.  [Tuberculosis prophylaxis].

Authors:  Z Müjgan Güler; A Berna Dursun
Journal:  Tuberk Toraks       Date:  2003

5.  Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period.

Authors:  Douglas G Farmer; Dean M Anselmo; R Mark Ghobrial; Hasan Yersiz; Suzanne V McDiarmid; Carlos Cao; Michael Weaver; Jesus Figueroa; Khurram Khan; Jorge Vargas; Sammy Saab; Steven Han; Francisco Durazo; Leonard Goldstein; Curtis Holt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

Review 6.  Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation.

Authors:  F J Farrell; E B Keeffe; K M Man; J C Imperial; C O Esquivel
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

7.  Isoniazid-related hepatic failure in children: a survey of liver transplantation centers.

Authors:  Steven S Wu; Catherine S Chao; Jorge H Vargas; Harvey L Sharp; Martín G Martín; Sue V McDiarmid; Frank R Sinatra; Marvin E Ament
Journal:  Transplantation       Date:  2007-07-27       Impact factor: 4.939

8.  Right-lobe living-donor liver transplantation in adult patients with acute liver failure.

Authors:  M Ates; S Hatipoglu; A Dirican; B Isik; V Ince; M Yilmaz; C Aydin; C Ara; C Kayaalp; S Yilmaz
Journal:  Transplant Proc       Date:  2013-06       Impact factor: 1.066

9.  Liver injury during antituberculosis treatment: an 11-year study.

Authors:  M Døssing; J T Wilcke; D S Askgaard; B Nybo
Journal:  Tuber Lung Dis       Date:  1996-08

Review 10.  Anti-tuberculosis medication and the liver: dangers and recommendations in management.

Authors:  N P Thompson; M E Caplin; M I Hamilton; S H Gillespie; S W Clarke; A K Burroughs; N McIntyre
Journal:  Eur Respir J       Date:  1995-08       Impact factor: 16.671

  10 in total
  1 in total

1.  Living Donor Re-transplantation for Repeated Acute Liver Failure.

Authors:  V Ince; C Kayaalp; E Otan; F Ozdemir; A Dirican; H I Toprak; C Aydin; C Ara; S Yilmaz
Journal:  Int J Organ Transplant Med       Date:  2018-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.